Back to Search
Start Over
Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data
- Source :
- Frontiers in Pharmacology, Vol 13 (2022)
- Publication Year :
- 2022
- Publisher :
- Frontiers Media S.A., 2022.
Details
- Language :
- English
- ISSN :
- 16639812 and 33495424
- Volume :
- 13
- Database :
- Directory of Open Access Journals
- Journal :
- Frontiers in Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.0b33495424ee0960ea530c0c39940
- Document Type :
- article
- Full Text :
- https://doi.org/10.3389/fphar.2022.990048